Rima Al-awar

Director/Board Member at SATELLOS BIOSCIENCE INC.

Net worth: - $ as of 30/04/2024

Health Technology

Health Services

Consumer Services

Profile

Rima Al-awar is currently the Director at Satellos Bioscience, Inc. and has been a Member at Ontario Institute for Cancer Research since 2008.
She holds a doctorate degree from North Carolina State University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SATELLOS BIOSCIENCE INC -.--%	29/05/2023	0 ( -.--% )	- $	30/04/2024

Rima Al-awar active positions

Companies	Position	Start
SATELLOS BIOSCIENCE INC.	Director/Board Member	05/12/2021
Ontario Institute for Cancer Research Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada.	Corporate Officer/Principal	01/01/2008

All active positions of Rima Al-awar

Training of Rima Al-awar

North Carolina State University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rima Al-awar's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SATELLOS BIOSCIENCE INC.	Health Technology

Private companies	1
Ontario Institute for Cancer Research Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada.	Health Services